American Ginseng in Treating Patients With Fatigue Caused by Cancer

1. Required characteristics * ≥ 18 years of age * Men or women with a history of cancer-related fatigue as defined by an average score ≥ 4 over the past 30 days on the numeric analogue scale (1 - 10) * The presence of fatigue ≥ 1 month prior to randomization * ECOG performance score 0, 1, or 2 * Histologic or cytologic proven cancer other than brain cancer or CNS lymphoma, undergoing curative intent therapy (including anti-hormonal therapies such as tamoxifen or leuprolide) or those having completed curative intent therapy who were diagnosed within the past 2 years * Note: If a patient is receiving treatment for their disease such as chemotherapy, targeted therapies, immunotherapy or radiation therapy then, the patient must have completed ≥ 1 cycle of chemotherapy, targeted therapy, or ≥ 1 week of radiation treatment. * Laboratory values obtained prior to randomization: * Hgb ≥ 11 (must be obtained ≤ 30 days; patients must not be transfused ≤ 30 days to meet this criterion) * Creatinine ≤ 1.2 x UNL (must be obtained ≤ 180 days prior to randomization) * AST (SGOT) or ALT (SGPT) ≤ 1.5 x UNL (must be obtained ≤ 180 days prior to randomization) * Negative pregnancy test done ≤ 7 days prior to registration, for women of childbearing potential only * Ability to complete patient questionnaires alone or with assistance * Controlled: * Pain (≤ 4 on Linear Analogue Scale) * Insomnia (≤ 4 on Linear Analogue Scale) * Willing…